Cargando…
Digoxin and Standard-of-Care Therapy for Heart Failure Patients with COVID-19: Analysis of Data from the US Military Health System (MHS) Data Repository
BACKGROUND: Cardiac glycosides such as digoxin, digitoxin and ouabain are still used around the world to treat patients with chronic heart failure with reduced ejection fraction (HFrEF) and/or atrial fibrillation (AF). However, in the US, only digoxin is licensed for treating these illnesses, and th...
Autores principales: | Banaag, Amanda L., Pollard, Harvey B., Koehlmoos, Tracey P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024520/ https://www.ncbi.nlm.nih.gov/pubmed/36933173 http://dx.doi.org/10.1007/s40801-023-00360-8 |
Ejemplares similares
-
The burden of vestibular disorders among military health system (MHS) beneficiaries, fiscal years 2018–2019
por: Sayegh, M. Aaron, et al.
Publicado: (2023) -
Antibiotic Prescribing Patterns and Guideline Concordance for Uncomplicated Urinary Tract Infections Among Adult Women in the US Military Health System
por: Kikuchi, Jacqueline Y., et al.
Publicado: (2022) -
Trends in Telehealth Care During the COVID-19 Pandemic for the Military Health System
por: Gilder, Thomas, et al.
Publicado: (2023) -
A Cohort Study Comparing Pediatric Patients with Overweight and Obesity in the Military Health System
por: Espinola, Dimas C., et al.
Publicado: (2021) -
Changes in body mass index and behavioral health among adolescents in military families during the COVID-19 pandemic: a retrospective cohort study
por: Koehlmoos, Tracey Pérez, et al.
Publicado: (2023)